首页> 美国卫生研究院文献>Scientific Reports >High-throughput preparation methods of crude extract for robust cell-free protein synthesis
【2h】

High-throughput preparation methods of crude extract for robust cell-free protein synthesis

机译:高通量的粗提物制备方法用于稳定的无细胞蛋白质合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Crude extract based cell-free protein synthesis (CFPS) has emerged as a powerful technology platform for high-throughput protein production and genetic part characterization. Unfortunately, robust preparation of highly active extracts generally requires specialized and costly equipment and can be labor and time intensive. Moreover, cell lysis procedures can be hard to standardize, leading to different extract performance across laboratories. These challenges limit new entrants to the field and new applications, such as comprehensive genome engineering programs to improve extract performance. To address these challenges, we developed a generalizable and easily accessible high-throughput crude extract preparation method for CFPS based on sonication. To validate our approach, we investigated two Escherichia coli strains: BL21 Star™ (DE3) and a K12 MG1655 variant, achieving similar productivity (defined as CFPS yield in g/L) by varying only a few parameters. In addition, we observed identical productivity of cell extracts generated from culture volumes spanning three orders of magnitude (10 mL culture tubes to 10 L fermentation). We anticipate that our rapid and robust extract preparation method will speed-up screening of genomically engineered strains for CFPS applications, make possible highly active extracts from non-model organisms, and promote a more general use of CFPS in synthetic biology and biotechnology.
机译:基于粗提物的无细胞蛋白质合成(CFPS)已经成为用于高通量蛋白质生产和遗传部分鉴定的强大技术平台。不幸的是,高活性提取物的稳健制备通常需要专用且昂贵的设备,并且可能是劳动和时间密集的。此外,细胞裂解程序可能难以标准化,从而导致各个实验室的提取物性能不同。这些挑战限制了该领域的新进入者和新的应用,例如提高提取性能的综合基因组工程计划。为了解决这些挑战,我们开发了一种基于超声处理的通用且易于使用的CFPS高通量原油提取物制备方法。为了验证我们的方法,我们研究了两种大肠杆菌菌株:BL21 Star™(DE3)和K12 MG1655变体,仅改变几个参数即可达到相似的生产率(以g / L定义为CFPS产量)。此外,我们观察到从跨越三个数量级的培养体积(10 µmL培养管至10 µL发酵液)产生的细胞提取物的生产率相同。我们预计,我们快速而稳定的提取物制备方法将加快针对CFPS应用的基因工程菌株的筛选,使非模型生物的高活性提取物成为可能,并促进CFPS在合成生物学和生物技术中的更广泛使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号